Baseline laboratory panel: difference between revisions

Diff·revision 1 → 2·05:55, 28 Oct 2024

Difference between revision 1 and revision 2 of Baseline laboratory panel. 12 lines changed; the page grew by 671 bytes.

Revision 1 — 11:48, 22 Oct 2024 A1c_Alder (talk) create article — laboratory stub 1,276 bytes +1,276	Revision 2 — 05:55, 28 Oct 2024 ApoB_Aurelio (talk) add the citation for the imprecision figure 1,947 bytes +671
10	The principle that makes a baseline useful is consistency: the same analytes, on the same assay platform, under the same collection conditions. A follow-up measurement from a different laboratory may differ from the baseline by more than the intervention changed it. See [[Fasting insulin]] for the clearest example of between-assay variation.{{r\|wallace2004}}	10	The principle that makes a baseline useful is consistency: the same analytes, on the same assay platform, under the same collection conditions. A follow-up measurement from a different laboratory may differ from the baseline by more than the intervention changed it. See [[Fasting insulin]] for the clearest example of between-assay variation.{{r\|wallace2004}}
11		11
+		12	== Common components ==
+		13	\| Domain \| Typical analytes \|
+		14	\|---\|---\|
+		15	\| Glycaemic \| [[Haemoglobin A1c]], fasting glucose, [[Fasting insulin]] \|
+		16	\| Lipid \| Lipid panel, Apolipoprotein B where available \|
+		17	\| Hepatic \| Alanine transaminase, Gamma-glutamyl transferase \|
+		18	\| Renal \| Creatinine with eGFR, Urine albumin-to-creatinine ratio \|
+		19	\| Thyroid \| Thyroid function test \|
+		20	\| Other \| Vitamin B12 status, High-sensitivity C-reactive protein \|
+		21
+		22	The table lists analytes that appear in the literature and in the panels people discuss; it is not a recommendation, and which measurements are appropriate for any individual is a clinical question this wiki does not answer.{{r\|ada2024}}
+		23
12	== References ==	24	== References ==
13	{{reflist}}	25	{{reflist}}